Researchers Probe Genetics Behind a Lizard’s Odd Immune System

Deletions in the sleepy lizard genome leave it without an important type of T cells found in most other vertebrates.

Written byHannah Thomasy, PhD
| 4 min read
Tiliqua rugosa, sleepy lizard, on reddish soil in western Australia
Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Tiliqua rugosa—also known as the sleepy lizard—is a gorgeously chunky species, part lizard and part pinecone in appearance, which is found across the southern half of Australia. But it’s what’s on the inside that has captured the attention of researchers. Reptiles in general have immune systems that are unusual from a mammalian perspective; for example, they may rely more heavily on innate immunity and less on adaptive immunity, says University of New Mexico biologist Rob Miller. But the sleepy lizard (along with other scaled reptiles, a group known as squamates), may be even stranger.

Last month, Miller and an international team of scientists published a study in the Journal of Immunology comparing the sleepy lizard’s genome to that of the tuatara (a lizardlike animal that is the closest living relative of the squamates). The work revealed something strange: large deletions in the lizard’s genome resulted in the removal of genes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Hannah Thomasy, PhD headshot

    Hannah is an Assistant Editor at The Scientist. Her work has appeared in The New York Times, The Daily Beast, and Undark. She earned her PhD in neuroscience from the University of Washington where she studied traumatic brain injury and sleep. She completed the Dalla Lana Fellowship in Global Journalism in 2020. Outside of work, she enjoys running and aspires to be a participant on The Great Canadian Baking Show.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies